This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Denise Faustman, M.D., Ph.D.
Associate Professor of Medicine at Harvard Medical School


Dr. Faustman researchers and develops new therapeutic concepts to treat autoimmunity, cancer and infectious disease. She oversees a large multidisciplinary lab that conducts basic science through translation, clinical trial design, drug manufacturing and clinical trial implementation. The Faustman lab has uncovered the basic molecular and immunological mechanisms behind the immune imbalances in autoimmunity and cancer. She is international leader as it relates to the TNF superfamily of receptors with an emphasis on the TNFR2 signaling, a pathway that is deficient in autoimmunity and overactive in cancer and infectious disease. Her most advanced clinical trials, Phase II/III involve the use of the BCG vaccine, an inducer of TNFR2 signaling as a means via metabolism and Treg immunology to clinically impact Alzheimer’s and type 1 diabetes. She has published over one hundred peer review articles and book chapters and in 2017 was elected to the National Academy of Inventors in Washington DC for her contributions to immunology.

Agenda Sessions

  • The Use of Structure and Function to Make New Classes of Functional Antibodies to the TNF Superfamily: A Focus on TNFR2